×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Yahoo Finance
IGM Biosciences (IGMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
2 days ago
IGM Biosciences Upgraded to Buy: What Does It Mean for the Stock?
markets.businessinsider.com
Investors might want to bet on IGM Biosciences, Inc. (NASDAQ:IGMS), as it has been recently upgraded to a Zacks Rank #2 (Buy).
3 days ago
IGM Biosciences, Inc. (NASDAQ:IGMS) Given Average Rating of “Moderate Buy” by Analysts
Defense World
Read IGM Biosciences, Inc. (NASDAQ:IGMS) Given Average Rating of “Moderate Buy” by Analysts at Defense World.
1 day ago
IGM Biosciences Announces Refocusing of Sanofi Collaboration
GlobeNewswire
MOUNTAIN VIEW, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company...
2 weeks ago
Biopharma Layoff Tracker 2024: Emergent, BMS, CureVac and More Cut Staff
BioSpace
Follow along as BioSpace keeps you up-to-date on the latest pharma and biotech layoffs.
3 days ago
IGM jettisons workforce and blood cancer programme to refocus pipeline
Pharmaceutical Technology
IGM will lay off 22% of its staff and suspend four clinical activities to advance autoimmune diseases and colorectal cancer programmes.
4 months ago
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives $17.44 Average PT from Brokerages
MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eight research firms...
1 day ago
Is IGM Biosciences (NASDAQ:IGMS) In A Good Position To Invest In Growth?
Simply Wall Street
We can readily understand why investors are attracted to unprofitable companies. For example, although...
1 week ago
Sanofi, IGM Biosciences shave billions off research pact that deemphasizes cancer - San Francisco Business Times
The Business Journals
The 200-employee Peninsula drug company saw its stock fall more than 11%.
2 weeks ago
IGM Biosciences refines Sanofi antibody collaboration By Investing.com
Investing.com
MOUNTAIN VIEW, Calif. - IGM Biosciences, Inc. (NASDAQ:IGMS), a biotechnology firm specializing in engineered IgM antibodies, announced today...
2 weeks ago